BW
Barbara Weber
Director, Executive Chair

Barbara Weber insider trades: Tango Therapeutics (TNGX) stock sales

Director, Executive Chair, Tango Therapeutics Last trade Feb 3, 2026 22 Form 4 filings
$374K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2020
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Barbara reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 3, 2026TNGX↓ Sell$374K
Feb 5, 2025TNGX↓ Sell$58K
Oct 8, 2024RVMD↓ Sell$250K
Feb 7, 2024TNGX↓ Sell$115K
Sep 1, 2023RVMD↓ Sell$526K
Feb 4, 2021RVMD↓ Sell$252K
Feb 2, 2021RVMD↓ Sell$240K
Dec 30, 2020RVMD↓ Sell$219K
Oct 5, 2020RVMD↓ Sell$359K
Aug 13, 2020RVMD↓ Sell$56K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TNGX insiders

Open-market trades in the last 12 months

About Barbara Weber's insider trades

Barbara Weber is Director, Executive Chair at Tango Therapeutics (TNGX). Since Aug 13, 2020, Barbara has reported no open-market purchases and 10 sales worth $2.4M on SEC Form 4. In the last 12 months: 1 sale ($374K).

Their filings also include grants and awards (12 filings), option exercises (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TNGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.